COLLEGIUM PHARMACEUTICAL, INC (COLL) Shareholders’ equity 2016–2025
COLLEGIUM PHARMACEUTICAL, INC (COLL) shareholders’ equity at each fiscal year-end, per SEC filings.
$301.7MFY2025 · since FY2016: $134.9M → $301.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $301.7M | +31.8% |
| FY2024 | $228.8M | +17.1% |
| FY2023 | $195.4M | +0.3% |
| FY2022 | $194.8M | -4.0% |
| FY2021 | $202.9M | +9.1% |
| FY2020 | $186.0M | +112.8% |
| FY2019 | $87.4M | -4.5% |
| FY2018 | $91.6M | -12.0% |
| FY2017 | $104.1M | -22.9% |
| FY2016 | $134.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice